
Options bears are circling three stocks today, with Aemetis Inc (NASDAQ:AMTX), Acadia Pharmaceuticals Inc (NASDAQ:ACAD), and Resideo Technologies Inc (NYSE:REZI) all seeing puts handily outpace calls.
Aemetis, Inc. is a biochemical and renewable natural gas and fuels company in North America and India. The company is headquartered in Cupertino, California.
| Revenue (TTM) | $230.17M |
| Gross Profit (TTM) | $23.94M |
| EBITDA | $-1.58M |
| Operating Margin | 9.21% |
| Return on Equity | 0.00% |
| Return on Assets | -2.73% |
| Revenue/Share (TTM) | $3.44 |
| Book Value | $-4.47 |
| Price-to-Book | 141.51 |
| Price-to-Sales (TTM) | 0.46 |
| EV/Revenue | 2.398 |
| EV/EBITDA | -8.77 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 20.00% |
| Shares Outstanding | $72.17M |
| Float | $67.16M |
| % Insiders | 6.95% |
| % Institutions | 24.65% |
Volatility is currently contracting

Options bears are circling three stocks today, with Aemetis Inc (NASDAQ:AMTX), Acadia Pharmaceuticals Inc (NASDAQ:ACAD), and Resideo Technologies Inc (NYSE:REZI) all seeing puts handily outpace calls.

CUPERTINO, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a diversified renewable natural gas and biofuels company, today announced that it has received $22.4 million from the sale of Section 45Z Clean Fuel Production Tax Credits.

Dallas, Texas--(Newsfile Corp. - August 10, 2026) - Aemetis Inc. (NASDAQ: AMTX): Stonegate Capital Partners Updates Coverage on Aemetis Inc. (NASDAQ: AMTX). Aemetis' 2Q26 results made the operating inflection visible, as quarterly 45Z recognition, higher RNG production, and improved ethanol economics drove positive operating income and adj.

Aemetis, Inc. (AMTX) Q2 2026 Earnings Call Transcript

Aemetis NASDAQ: AMTX reported higher second-quarter revenue and a return to operating profitability, citing growth in its California ethanol and dairy renewable natural gas businesses as well as contributions from federal Section 45Z production tax credits.

Aemetis (AMTX) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.41 per share a year ago.

Revenue Growth of 20%, Positive Operating Income, and Increased Dairy RNG Production CUPERTINO, Calif., August 6, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aemetis, Inc.

CUPERTINO, Calif., August 4, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) - Aemetis, Inc.

ALTO and AMTX are pursuing distinct renewable fuel strategies as ethanol margins, tax credits and low-carbon initiatives shape their growth outlooks.

CUPERTINO, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its second quarter 2026 earnings report: Date: Thursday, August 6, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 423338 Live Participant Dial In (International): +1-973-528-0011 entry code 423338 Webcast URL: https://www.webcaster5.com/Webcast/Page/2211/54334 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMTX and any ticker you trade — then tracks every position and per-strategy win rate.